Related Experiment Videos

Future direction of neoadjuvant therapy for breast cancer

¹Department of Breast Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

Seminars in Oncology

|May 5, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Circulating tumor DNA dynamics in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer assessed using an ultrasensitive tumor-informed assay.

ESMO open·2026

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.

ESMO open·2026

Assessing Sensitization to Der p 23 and Inhibition of Specific IgE Using Commercial Extracts in House Dust Mite-Allergic Patients.

Journal of investigational allergology & clinical immunology·2025

Adjuvant capecitabine in patients with triple-negative breast cancer after neoadjuvant chemotherapy.

ESMO open·2025

Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆.

ESMO open·2024

Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

See all related articles